Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]

DRUG2 trials

Sponsors

Thomas Benfield, University Hospital, Caen

Conditions

HIV InfectionsHIV LipodystrophyHivObesityOsteoporosisRenal InsufficiencyWeight Gain

Phase 2

DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

RecruitingNCT06034938

University Hospital, CaenHiv

Start: 2024-02-08End: 2026-05-01Target: 32Updated: 2025-07-24

Phase 4

Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil

Thomas BenfieldHiv, HIV Infections, HIV Lipodystrophy +4

Start: 2021-02-02End: 2023-02-02Target: 126Updated: 2021-05-27